Is apixaban safer and more effective than rivaroxaban for individuals with atrial fibrillation?

New research suggests that for individuals with atrial fibrillation, the blood-thinning drug apixaban may be safer and more effective at preventing strokes and systemic blood clots compared with rivaroxaban. A team of researchers from Brigham and Women's Hospital, Harvard Medical School (both MA, USA), Sinai Health System and the University of Toronto (both ON, Canada), has evaluated the comparative safety and effectiveness of apixaban versus rivaroxaban for the prevention of stroke and/or systemic blood clotting in individuals with atrial fibrillation. The results of the large cohort study suggest apixaban may exhibit superior safety and effectiveness over rivaroxaban. Individuals with atrial...